Market revenue in 2023 | USD 587.2 million |
Market revenue in 2030 | USD 770.4 million |
Growth rate | 4% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Powder delivery device |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 43.09% in 2023. Horizon Databook has segmented the UAE intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
The intranasal drug and vaccine delivery market in UAE holds considerable market value in the country. UAE has developed very rapidly from developing country with large nomadic population. This economic progress has brought opportunities and social benefits in the country.
Improvements in the performance of healthcare systems is among the key goals of the UAE national strategy. Key performance indicators include population health targets, such as reducing tobacco consumption & increasing life expectancy, along with structural and organizational targets, including regulatory requirements for all healthcare facilities to be externally accredited.
The launch of tracking system by mid-2020 in Dubai will enable the Dubai Health Authority to monitor and trace medicines, with an aim to improve patient safety. Thus, increasing number of approvals is expected to ensure availability of high-quality medical devices in UAE, thereby propelling market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into UAE intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account